| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2020 | CDNA Caredx, Inc. | Maag Peter83 | Chief Executive Officer | Sell | 10,000 | $17.39 | $173,873.00 | -2.0% | |
| Mar 16, 2020 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 5,700 | $3.49 | $19,893.00 | +3.2% | |
| Mar 13, 2020 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Buy | 15,350 | $3.83 | $58,765.50 | +21.3% | |
| Mar 12, 2020 | OPK Opko Health, Inc. | Japour Anthony J | Director | Buy | 500 | $1.51 | $755.05 | +100.0% | |
| Mar 10, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 300,000 | $1.61 | $481,635.76 | - | |
| Mar 10, 2020 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 20,000 | $25.18 | $503,520.00 | -7.2% | |
| Mar 9, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 1,000 | $7.84 | $7,840.00 | -1.7% | |
| Mar 5, 2020 | CRL Charles River Laboratories International, Inc. | Barbo William D66 | Corporate Executive VP &CCO | Sell | 13,966 | $164.35 | $2,295,299.65 | -27.1% | |
| Mar 4, 2020 | GH Guardant Health, Inc. | Kaul Samir | Director | Sell | 25,000 | $82.38 | $2,059,540.00 | -8.0% | |
| Mar 4, 2020 | TMO Thermo Fisher Scientific Inc. | Stevenson Mark59 | Executive Vice President &COO | Sell | 25,000 | $324.28 | $8,107,000.00 | -34.0% | |
| Mar 4, 2020 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 8,700 | $318.54 | $2,771,298.00 | -17.7% | |
| Mar 4, 2020 | DHR Danaher Corp /de/ | Daniel William K | EVP | Sell | 0 | $147.54 | $65.32 | - | |
| Mar 4, 2020 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 98,093 | $30.86 | $3,027,149.98 | -39.3% | |
| Mar 4, 2020 | TMO Thermo Fisher Scientific Inc. | Lagarde Michel62 | Executive Vice President | Sell | 24,000 | $319.18 | $7,660,200.00 | -27.0% | |
| Mar 3, 2020 | OPK Opko Health, Inc. | Japour Anthony J | Director | Buy | 500 | $1.47 | $735.00 | New | |
| Mar 3, 2020 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 3,494 | $83.81 | $292,832.14 | -2.5% | |
| Mar 3, 2020 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 32,881 | $25.39 | $834,798.13 | -16.6% | |
| Mar 3, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,690 | $78.33 | $210,707.70 | -67.4% | |
| Mar 3, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.47 | $147,000.00 | - | |
| Mar 2, 2020 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 2,500 | $291.03 | $727,575.00 | -5.8% | |
| Mar 2, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.49 | $148,978.00 | - | |
| Mar 2, 2020 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 2,867 | $82.00 | $235,094.00 | -2.0% | |
| Mar 2, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 1,000 | $8.76 | $8,760.00 | -1.7% | |
| Mar 2, 2020 | NEO Neogenomics Inc | Jones Steven C | Director | Sell | 297,300 | $28.77 | $8,554,252.00 | -15.9% | |
| Feb 28, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 125,000 | $1.46 | $182,099.46 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.